hotspot -WSS

hotspot

author：explore 2025-10-02 21:05:26 - browse：69316

Alphabet’s life sciences company Verily has scored its first Centers for Disease Control and Prevention contract, a high profile job leaders hope will boost its brand in public health as well as its nascent wastewater surveillance business, executives told STAT.

Under the up-to-five year, $38 million contract, Verily will collect samples from hundreds of wastewater treatment centers across the country, analyze them for Covid-19 and the mpox virus at its South San Francisco lab, and return the data to CDC within 36 hours of collecting the samples. The contract is limited to those two pathogens but the company is prepared to analyze more if needed, leaders said.

The contract comes as Verily struggles to turn a profit among various disparate health care offerings, like value-based care analytics for health systems, clinical trial software and even an in-person substance use rehabilitation center in Ohio. Despite several prominent hires and a vast number of projects, the company has yet to forge a sustainable business.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： 'The Exorcist' director William Friedkin dead at 87

WSS

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Trump Jan. 6 attorney John Lauro is ex

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

NYC plans to house migrants on an island in the East River

How to bring more disabled researchers into academia

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

knowledge

hotspot

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Amylyx ALS drug failure raises questions and concerns

United colonoscopy coverage change 'may cost lives,' doctors say

RSV shot was 90% effective at preventing hospitalizations in kids

DIEP, the 'gold standard' of breast reconstruction, is under threat

Trump Jan. 6 attorney John Lauro is ex

United colonoscopy coverage change 'may cost lives,' doctors say

'The Exorcist' director William Friedkin dead at 87

Bright Health sells Medicare Advantage business to Molina

First medicine developed to treat MASH expected to be approved soon

knowledge

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

The Readout: Amylyx, Alumis, and Lundbeck drug updates

CDC marks new Covid

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

leisure time

focus

hotspot

focus